Racial/ethnic disparities identified in ophthalmology trials

Credit: Pixabay/CC0 Public Domain

(HealthDay)—Black and Hispanic or Latinx participants are underrepresented in clinical trials for ophthalmology drugs, according to a study published online April 22 in JAMA Ophthalmology.

Sean T. Berkowitz, from the Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues examined racial/ethnic representation, trends, and disparities for participants in clinical leading to U.S. Food and Drug Administration ophthalmology approvals for neovascular age-related macular degeneration (AMD), open-angle glaucoma (OAG), and expanded indications for (DR) from Jan. 1, 2000, to Dec. 31, 2020. Thirty-one clinical trials were identified for 13 medications with 18,410 participants.

The researchers found that for most approvals, the distribution of trial participants was different from the expected trial distribution with respect to race/ethnicity (12 drugs) and sex (10 drugs). Trials conducted in 2011 to 2020 versus 2000 to 2010 showed increases in enrollment of Asian and Hispanic or Latinx participants for AMD (odds ratios, 2.30 and 1.74, respectively); Asian participants for DR (odds ratio, 2.21); and Black and Hispanic or Latinx participants for OAG (odds ratios, 1.60 and 10.31, respectively). In DR trials, there was a decrease in Black participants (odds ratio, 0.58). Based on these trends, by 2050, the enrollment incidence ratio is expected to worsen with overrepresentation of Whites and underrepresentation of Black and Hispanic or Latinx participants in trials of drugs for AMD, DR, and OAG.

"Diverse, representative enrollment in pivotal is vital to sufficiently power subgroup analyses and ensure equity and validity of trial results," the authors write.

One author disclosed receiving grants from Alcon.

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal information: JAMA Ophthalmology

Copyright © 2021 HealthDay. All rights reserved.

Citation: Racial/ethnic disparities identified in ophthalmology trials (2021, April 27) retrieved 30 May 2024 from https://medicalxpress.com/news/2021-04-racialethnic-disparities-ophthalmology-trials.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Globalization of cancer clinical trials linked to lower enrollment of Black patients


Feedback to editors